Download TUMORS OF THE SALIVARY GLANDS

TUMORS OF THE SALIVARY
GLANDS
TUMORS OF THE SALIVARY GLANDS
MASSES
DIFFERENTIAL DIAGNOSIS OF A SALIVARY
GLAND MASS:
INFLAMMATION (PAROTIDITIS) –
MUMPS –
CALCULI –
NEOPLASM –

TUMORS OF THE SALIVARY GLANDS
INCIDENCE: 3/100,000 
3%ALL BODY TUMORS 
LOCATION OF SALIVARY GLAND TUMORS: 85% 
PAROTID, 10% SUBMANDIBULAR, 1% SUBLINGUAL, 45% MINOR SALIVARY GLANDS
TUMORS OF THE SALIVARY GLANDS
BENIGN MASSES
80%OF ALL BENIGN LESIONS ARISE IN THE
LATERAL (TAIL) OF THE PAROTID GLAND.
SUPERFICIAL PAROTIDECTOMY WITH 
PRESERVATION OF THE FACIAL NERVE
TOTAL SUBMANDIBULAR AND SUBLINGUAL
GLAND RESECTION


TUMORS OF THE SALIVARY GLANDS
BENIGN MASSES
PLEOMORPHIC ADENOMA
BENIGN MIXED TUMOR

MYOEPITHELIAL AND EPIDERMOID CELL ORIGIN
MOST COMMON NEOPLASM IN THE PAROTID
GLAND ACCOUNTS FOR 65% OF ALL OF THE
PAROTID TUMORS.


TUMORS OF THE SALIVARY GLANDS
BENIGN MASSES
PLEOMORPHIC ADENOMA
TREATMENT: WIDE RESECTION OF THE TUMOR
AVOID SHELLING OUT THE LESION


RECURRENCE: PRIMARY DUE TO INADEQUATE
RESECTION

LESIONS ARE MORE AGGRESSIVE WHEN THEY
RECUR.

TUMORS OF THE SALIVARY GLANDS
BENIGN MASSES
WARTHIN’S TUMOR (ADENOLYMPHOMA)
SECOND MOST COMMON PAROTID TUMOR
MALE : FEMALE 5 : 1
BILATERAL 10%



PRIMARILY LOCATED IN THE LATERAL GLAND HOWEVER
MULTICENTRICITY IS DESCRIBED.
PEA SOUP BROWN MUCOID MATERIAL ON SECTIONING


TREATMENT: LATERAL OR TOTAL GLANDULAR RESECTION

TUMORS OF THE SALIVARY GLANDS
BENIGN MASSES
WARTHIN’S TUMOR (ADENOLYMPHOMA)
90%CURED WITH RESECTION

10%RECUR DUE TO MULTICENTRICITY OR
INADEQUATE RESECTION.

TUMORS OF THE SALIVARY GLANDS
BENIGN MASSES
ONCOCYTOMA
PRINCIPALLY A PAROTID GLAND TUMOR
5TH DECADE


PROBABLY DUE TO HYPERPLASIA FROM AGING
>1%SALIVARY GLAND TUMORS

CYSTIC COMPONENT HAS BEEN IDENTIFIED.


TUMORS OF THE SALIVARY GLANDS
BENIGN MASSES
BASAL CELL ADENOMA
COMMON IN THE LATERAL PAROTID AND THE
SUBMUCOSAL GLANDS IN THE UPPER LIP.
TREATMENT: LATERAL OR TOTAL GLANDULAR
RESECTION.


TUMORS OF THE SALIVARY GLANDS
BENIGN MASSES
HEMANGIOMA
50%OF ALL PAROTID TUMORS IN CHILDREN

TREATMENT: ENVOLUTION BY THE AGE OF 5 IS
COMMON
CN VII: SUPERFICIAL LOCATION IN CHILDREN 
THUS OPERATIVE INTERVENTION SHOULD BE
AVOIDED AND LET ENVOLUTION PROCEED
UNLESS THERE IS UNCONTROLLED BLEEDING.
STEROID THERAPY


TUMORS OF THE SALIVARY GLANDS
BENIGN MASSES
LIPOMA
4%OF ALL PAROTID TUMORS 
MALE PREDOMINANCE 
4-5%TH DECADE 
TREATMENT: LATERAL OR TOTAL GLANDULAR
RESECTION

TUMORS OF THE SALIVARY GLANDS
BENIGN MASSES
MYXOMA
SLOW GROWING
INFILTRATIVE


TREATMENT: WIDE RESECTION OR TOTAL
GLANDULAR REMOVAL

TUMORS OF THE SALIVARY GLANDS
MALIGNANT MASSES
PROGNOSIS: PALATE > PAROTID > SUBMANDIBULAR /
SUBLINGUAL GLAND
5TH-6TH DECADE


RATE OF GROWTH DOES NOT CORRELATE WITH THE
DEGREE OF MALIGNANCY
LUNG/BONE: PRIMARY METASTATIC SITES

PRIOR RADIOTHERAPY INCREASES THE RISK OF A
SALIVARY GLAND MALIGNANCY.


TUMORS OF THE SALIVARY GLANDS MALIGNANT
MASSES
MUCOEPIDERMOID CARCINOMA
MUCOUS AND EPIDERMOID CELL ORIGIN 
6%OF ALL PAROTID TUMORS - MOST COMMON
MALIGNANCY
65%FOUND IN THE PAROTID GLAND 
18%OF ALL MALIGNANT TUMORS OF THE 
SALIVARY GLANDS

TUMORS OF THE SALIVARY GLANDS MALIGNANT
MASSES
MUCOEPIDERMOID CARCINOMA
LOW, INTERMEDIATE AND HIGH GRADES
4-6TH DECADE


8%CN VII INVOLVEMENT AT THE TIME OF
PRESENTATION
10%LYMPH NODE METASTASIS


TUMORS OF THE SALIVARY GLANDS MALIGNANT MASSES
MUCOEPIDERMOID CARCINOMA
TREATMENT: TOTAL GLANDULAR RESECTION
+/- NECK NODE DISSECTION

CN VII: SPARE NERVE UNLESS INVOLVED WITH
TUMOR.

POSTOPERATIVE RADIOTHERAPY DEPENDING
ON MARGINS, EXTRACAPSULAR EXTENSION
FROM LYMPH NODES, PERINEURAL
INVOLVEMENT, OR INVOLVEMENT OF
SURROUNDING STRUCTURES

TUMORS OF THE SALIVARY GLANDS MALIGNANT
MASSES
MUCOEPIDERMOID CARCINOMA
RECURRENCE RATE 15-25%, USUALLY DUE TO
INADEQUATE RESECTION.
WHEN MUCUOEPIDERMOID CARCINOMA IS 
LOCATED IN THE SUBMANDIBULAR GLAND, THE
TUMOR IS MORE AGGRESSIVE.
RARELY INVOLVES THE SUBLINGUAL GLAND


TUMORS OF THE SALIVARY GLANDS
MALIGNANT MASSES
ADENOID CYSTIC CARCINOMA (CYLINDROMA)
MOST COMMON MALIGNANT TUMOR OF THE
SUBMANDIBULAR GLANDS AND THE SECOND
MOST COMMON PAROTID MALIGNANCY
25-30%CN VII PARALYSIS/PARESIS ON
PRESENTATION
PERINEURAL INVASION IS COMMON


GRAY PINK WITH CRIBRIFORM HISTOLOGY


TUMORS OF THE SALIVARY GLANDS
MALIGNANT MASSES
ADENOID CYSTIC CARCINOMA (CYLINDROMA)
UNPREDICTABLE TUMOR

SLOW GROWING, HOWEVER, RELENTLESS
DISEASE
LUNG METASTASIS COMMON


LYMPH NODE INVOLVEMENT NOT COMMON

TUMORS OF THE SALIVARY GLANDS
MALIGNANT MASSES
ADENOID CYSTIC CARCINOMA (CYLINDROMA)
TREATMENT: SURGICAL RESECTION OF THE 
GLAND WITH POSSIBLE NERVE RESECTION IF
INVOLVED
POSTOPERATIVE RADIOTHERAPY

MALIGNANT PLEOMORPHIC ADENOMA
(MALIGNANT MIXED TUMOR
OR CARCINOMA EX PLEOMORPHIC ADENOMA)
ETIOLOGY: MALIGNANT TRANSFORMATION OF A
PLEOMORPHIC ADENOMA
5-6TH DECADE 
AVERAGE DURATION OF THE LESION IS 
PRESENT 10 YEARS BEFORE BEING
DIAGNOSED
TREATMENT: GLANDULAR RESECTION WITH 
NERVE RESECTION IF INVOLVED WITH TUMOR

ACINOUS (ACINIC) CELL CARCINOMA
LOW, INTERMEDIATE AND HIGH GRADE 
INTRAVASCULAR EXTENSION 
3RD-6TH DECADE 
METASTASIS TO THE LUNG AND BONE (VERTEBRAE)
TREATMENT: GLANDULAR RESECTION 
RADIOTHERAPY IS NOT EFFECTIVE 

TUMORS OF THE SALIVARY GLANDS
MALIGNANT MASSES
SQUAMOUS CELL CARCINOMA
IS IT A METASTATIC LESION? 
1/3HAVE FACIAL NERVE INVOLVEMENT AT THE
TIME OF PRESENTATION
MALE > FEMALE

6TH DECADE 
TOTAL GLANDULAR RESECTION
10YEAR SURVIVAL: 45% 


ADENOCARCINOMA
USUALLY FIXED TO THE SURROUNDING STRUCTURES 
MALE > FEMALE 
3RD - 6TH DECADE 
22%FACIAL NERVE INVOLVEMENT AT THE TIME OF PRESENTATION
25%METASTASIS AT THE TIME OF PRESENTATION 
GLANDULAR RESECTION WITH NERVE RESECTION IF INVOLVED 
WITH TUMOR
NECK DISSECTION 
POSTOPERATIVE RADIOTHERAPY 

TUMORS OF THE SALIVARY GLANDS
MALIGNANT MASSES
UNDIFFERENTIATED CARCINOMA
7TH-8TH DECADE 
33%FACIAL NERVE INVOLVEMENT AT THE TIME
OF PRESENTATION
HIGHLY MALIGNANT

TREATMENT: GLANDULAR RESECTION, NECK 
DISSECTION, POSTOPERATIVE RADIOTHERAPY
NERVE RESECTION IF INVOLVED


TUMORS OF THE SALIVARY GLANDS
COMPLICATIONS OF SURGICAL INTERVENTION
ORAL FISTULAS 
FACIAL NERVE INJURY 
LOSS OF EAR SENSATION 
FREY’S SYNDROME (GUSTATORY SWEATING)
SKIN NECROSIS 
